Investigators seeking to buy GHRP-2 peptide for laboratory research require analytical purity, verified sequence integrity, and strict lot-to-lot consistency. PX1 Research supplies USA-manufactured, highly purified (>99% by HPLC) GHRP-2 with lot-specific Certificate of Analysis documentation, mass spectrometry verification, and quantitative endotoxin testing for valid in vitro and preclinical research applications.
Investigators seeking to buy GHRP-2 peptide for laboratory research require analytical purity, verified sequence integrity, and strict lot-to-lot consistency. PX1 Research supplies USA-manufactured, highly purified (>99% by HPLC) GHRP-2 with lot-specific Certificate of Analysis documentation, mass spectrometry verification, and quantitative endotoxin testing for valid in vitro and preclinical research applications.
Growth Hormone Releasing Peptide-2 (GHRP-2), also known as pralmorelin, is a synthetic hexapeptide belonging to the growth hormone secretagogue (GHS) class. Structurally defined as D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2, this non-natural peptide sequence was engineered to target the growth hormone secretagogue receptor 1a (GHS-R1a), mimicking the endogenous ligand ghrelin while exhibiting enhanced metabolic stability in laboratory buffer systems.
In chemical structure assays, GHRP-2 exhibits a molecular weight of 817.9 g/mol. Unlike endogenously produced peptide hormones that feature native L-amino acid configurations, GHRP-2 incorporates specific D-amino acid substitutions—namely D-alanine, D-2-naphthylalanine, and D-phenylalanine. These structural modifications protect the molecule from rapid enzymatic cleavage by circulating peptidases in ex vivo tissue preparations, making it a robust compound for secretagogue pharmacology research.
In vitro receptor binding assays demonstrate that GHRP-2 acts as a potent, high-affinity agonist at the GHS-R1a site, a seven-transmembrane G-protein-coupled receptor primarily localized in the anterior pituitary gland and hypothalamic nuclei. Binding of GHRP-2 to GHS-R1a stimulates the Gq/11 protein subunit, activating phospholipase C (PLC) signaling pathways within targeted somatotropic cells.
This enzymatic activation generates second messengers inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). IP3 triggers the rapid release of intracellular calcium ions (Ca2+) from the endoplasmic reticulum, while DAG activates protein kinase C (PKC). Preclinical cell culture models show that this dual signaling event facilitates the exocytosis of stored growth hormone granules without suppressing native transcription pathways, providing researchers with a distinct model for analyzing pulsed hormone secretion.
Preclinical investigations utilizing isolated rodent anterior pituitary cells indicate that exposure to GHRP-2 induces a rapid, concentration-dependent release of growth hormone. Unlike growth hormone-releasing hormone (GHRH), which operates via the adenylate cyclase/cAMP pathway, GHRP-2 utilizes distinct calcium-dependent cascades. When co-administered in vitro with GHRH, GHRP-2 exhibits a synergistic effect on hormone secretion amplitude, suggesting convergent downstream signaling mechanisms.
In rodent in vivo models, GHRP-2 administration has been studied for its effects on food intake kinetics and orexigenic pathways. Because GHS-R1a activation in the arcuate nucleus of the hypothalamus regulates appetite pathways via neuropeptide Y (NPY) and agouti-related protein (AgRP) neurons, GHRP-2 serves as an established tool for dissecting the neuroendocrine regulation of energy homeostasis, nutrient partitioning, and metabolic adaptation.
When designing comparative secretagogue protocols, investigators frequently contrast GHRP-2 with alternative GHS-R1a agonists and GHRH analogs available in our catalog of research peptides. GHRP-2 exhibits significantly higher receptor affinity and potency for GH release in pituitary cell culture assays than its predecessor, GHRP-6 research models. However, GHRP-6 demonstrates stronger orexigenic stimulation in hypothalamic tissue preparations.
Conversely, selective secretagogues such as Ipamorelin peptide show high specificity for GHS-R1a without triggering secondary cortisol or prolactin release in animal models. When evaluating synergistic signaling dynamics, researchers often combine GHS agonists with GHRH analogs such as CJC-1295 Without DAC to study dual-receptor activation of somatotropes. Understanding these operational nuances allows laboratories to select the precise compound for their experimental design.
Maintaining experimental reproducibility requires peptides that meet rigorous analytical standards. Every batch when you buy GHRP-2 peptide from PX1 Research undergoes rigorous verification protocols to ensure structural identity and chemical purity. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) is utilized to measure peptide purity, ensuring a threshold exceeding 99% with minimal target-related truncations or residual synthesis byproducts.
Electrospray Ionization Mass Spectrometry (ESI-MS) confirms the exact molecular weight and amino acid sequence integrity, eliminating baseline errors caused by isomeric impurities. Every shipment includes a lot-specific Certificate of Analysis (COA) generated by an independent, ISO 17025-accredited laboratory, allowing investigators to verify analytical data prior to beginning assays.
Bacterial endotoxins (lipopolysaccharides) pose a significant threat to cell culture viability, receptor binding kinetics, and gene expression studies by inducing non-specific inflammatory signaling via Toll-like receptor 4 (TLR4). For reliable assay results, laboratory reagents must adhere to strict endotoxin thresholds.
PX1 Research performs quantitative Chromogenic Recombinant Factor C (rFC) or Limulus Amebocyte Lysate (LAL) testing on all peptide lots. Our GHRP-2 research compounds are guaranteed to contain endotoxin levels below 0.01 EU/mg. This level of purity prevents cell toxicity and immune system activation, protecting sensitive primary pituitary and hypothalamic cell cultures during sensitive downstream analyses.
GHRP-2 is supplied as a lyophilized (freeze-dried) powder under vacuum sealing to maintain long-term peptide stability. For laboratory reconstitution, research personnel should use sterile, laboratory-grade solvents such as 0.9% Bacteriostatic Sodium Chloride or Sterile Water for Injection, depending on assay specifications. Solvents should be introduced along the internal glass vial wall to prevent shear stress on the peptide structure.
Gentle rotational swirling is recommended to achieve complete dissolution; vortexing should be strictly avoided as mechanical agitation can induce peptide aggregation or denaturation. Once reconstituted, stock solutions should be aliquoted into single-use polypropylene microtubes and stored at -20°C or -80°C to prevent degradation from repeated freeze-thaw cycles. Detailed reconstitution math and stability profiles are available in the PX1 research repository.
Lyophilized GHRP-2 demonstrates excellent chemical stability when stored under controlled environment conditions. For optimal shelf life, unopened vials should be kept desiccated at -20°C, protected from direct light exposure. Under these conditions, the peptide maintains structural integrity for up to 24 months from the manufacturing date.
Following reconstitution, liquid aliquots are stable at 4°C for up to 7 to 14 days, provided sterile handling procedures are maintained. For long-term storage of liquid stock solutions, holding at -80°C prevents peptide hydrolytic degradation. Laboratory protocols should account for temperature control during extended experimental timeframes to ensure reproducible binding kinetics.
PX1 Research is dedicated to supporting scientific discovery by maintaining standard-setting manufacturing and quality-control standards. All peptides offered across our growth hormone secretagogues category are synthesized in state-of-the-art, GMP-compliant facilities located entirely within the United States.
Orders are dispatched directly from our dual logistics hubs in California and Arizona, utilizing climate-controlled storage and expedited same-day shipping (Monday through Friday). For academic institutions, biotechnology organizations, and contract research organizations (CROs) requiring large-volume procurement, our bulk institutional orders division offers specialized batch reservation, custom vial configurations, and direct supply-chain transparency.
What is the certified purity level of PX1 Research GHRP-2?
PX1 Research guarantees a minimum purity of 99% for GHRP-2, as verified by lot-specific Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Mass Spectrometry (MS) testing.
What is the target receptor for GHRP-2 in laboratory models?
GHRP-2 selectively targets and binds to the growth hormone secretagogue receptor 1a (GHS-R1a), initiating downstream intracellular calcium mobilization via the phospholipase C (PLC) pathway.
How does GHRP-2 differ structurally from native ghrelin?
Ghrelin is a 28-amino acid endogenous peptide containing an n-octanoylated serine residue, whereas GHRP-2 is a synthetic hexapeptide (6 amino acids) featuring D-amino acid substitutions designed for enzymatic stability in research models.
What endotoxin standards apply to PX1 Research peptides?
All peptide lots undergo quantitative LAL endotoxin testing and are confirmed to contain less than 0.01 EU/mg, preventing non-specific immune signaling or cell culture toxicity.
What solvent is recommended for reconstituting GHRP-2 for in vitro studies?
Reconstitution is typically performed using sterile bacteriostatic water (0.9% benzyl alcohol) or sterile 0.9% saline, depending on the requirements of the biological assay and cell line sensitivity.
Where are PX1 Research compounds manufactured and shipped from?
All PX1 Research compounds are manufactured in USA-based, GMP-compliant facilities and shipped directly from fulfillment centers in California and Arizona with same-day dispatch for orders placed M–F.
How should reconstituted GHRP-2 stock solutions be stored?
Reconstituted GHRP-2 should be divided into single-use aliquots to prevent freeze-thaw cycles and stored at -20°C or -80°C for long-term experimental use.
Is GHRP-2 suitable for human consumption or therapeutic administration?
No. GHRP-2 provided by PX1 Research is strictly designated for laboratory research, in vitro assays, and preclinical animal studies. It is not for human or veterinary use, therapy, or clinical administration.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.